Centro de Tratamento Oncologico LTDA - CTO

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Triple-negative breast cancer

Running trials

• Active, not recruiting

  Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

  NCT03562637· Phase 3· OBI Pharma, Inc· Source